INSMED Inc — Form 10-Q
Filed October 29, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 5/100
What the filing says
William H. Lewis (CEO) and Sara Bonstein (CFO) certified the 10-Q for period ended September 30, 2026, filed October 29, 2026. Both officers certify financial statements fairly present the company's condition and that disclosure controls and internal controls over financial reporting are effective. No material weaknesses, significant deficiencies, or fraud involving management were disclosed.
Why this rating
Routine Sarbanes-Oxley 302/906 certifications. Standard periodic disclosure with no reported control deficiencies or restatement triggers. Boilerplate executive attestation.
See more from October 29, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.